Showing results (11-20 of 16) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Expert Opinion on Therapeutic Targets|August 25, 2022
Liver X receptor: a potential target in the treatment of atherosclerosisShreya R Savla, Kedar S Prabhavalkar, Lokesh K BhattFrontiers in Pharmacology|June 1, 2017
Oncolytic Herpes Simplex Viral Therapy: A Stride toward Selective Targeting of Cancer CellsDhaval S Sanchala, Lokesh K Bhatt, Kedar S PrabhavalkarCurrent Protein & Peptide Science|September 15, 2018
Targeting Matrix Metalloproteinases for Diabetic Retinopathy: The Way Ahead?Ankita Solanki, Lokesh K Bhatt, Thomas P Johnston, et al.Journal of Biochemical and Molecular Toxicology|February 17, 2023
Sulfamethizole attenuates poloxamer 407-induced atherosclerotic neointima formation via inhibition of mTOR in C57BL/6 miceAnkita Solanki, Shreya R Savla, Maheshkumar R Borkar, et al.The Journal of Pharmacy and Pharmacology|March 3, 2007
Beta-blocking activity of PP-34, a newly synthesized aryloxypropanolamine derivative, and its cardioprotective effect against ischaemia/reperfusion injury in laboratory animalsLokesh K Bhatt, K Nandakumar, S L Bodhankar, et al.Journal of Experimental Pharmacology|May 18, 2016
Cardioprotective and β-adrenoceptor antagonistic activity of a newly synthesized aryloxypropanolamine derivative PP-36Lokesh K Bhatt, Jyotika Bansal, Poonam Piplani, et al.Pageof 2